Exenatide hence improves mitochondrial function, reduces oxidative stress and protects WFS1-deficient iPSC-derived neurons from apoptosis, supporting the therapeutic potential of GLP-1R agonists to prevent cerebellar neurodegeneration in Wolfram syndrome. Here, WFS1 is linked to Wolfram syndrome.